Stay updated on Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing Revision: v3.6.0. This indicates an internal update to the page or its documents rather than a change to the study data.
    Difference
    0.0%
    Check dated 2026-07-01T02:36:37.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    New user-guidance sections were added and recruitment status updated to No longer looking for participants; the Intervention/Treatment heading is standardized and a Revision: v3.6.0 tag is introduced while the old v3.5.5 tag is removed.
    Difference
    0.1%
    Check dated 2026-06-16T18:35:16.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, indicating a new version of the page. This likely reflects minor updates to layout or metadata, while the core study details remain unchanged.
    Difference
    0.0%
    Check dated 2026-06-09T14:48:08.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Updated the Ukraine location entries to use Kharkiv Oblast and Kharkiv, Kharkiv Oblast, Ukraine, 61024 instead of the previous Kharkivs’ka Oblast’ naming.
    Difference
    0.0%
    Check dated 2026-06-02T14:01:09.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    A new revision tag v3.5.4 was added, replacing the prior v3.5.3 to indicate a minor administrative update to the page documentation.
    Difference
    0.0%
    Check dated 2026-05-19T09:46:37.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    A new revision tag (v3.5.3) appears, replacing v3.5.2 and indicating a page-level update rather than changes to study details.
    Difference
    0.0%
    Check dated 2026-04-27T20:13:46.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial page.